APCure SAS logo

APCure SAS

APCure is a company developing active, specific, Immunotherapy products based on BacVac, a highly innovative technology that uses a live, harmless, bioengineered bacterial vector targeting various tumors and infectious diseases.

APCure was founded jointly by AltraBio SAS, a bioinformatics company located in Lyon (France), and TheREx academic laboratory in Grenoble (France). APCure technology was developed by TheREx, under the leadership of Pr B. Polack & Pr. B. Toussaint.

0
Management
0
Technology
0
Deals/Partnering
0
Research Pipeline
0
Funding
BioStartup's Score 0 / 50

KEY DETAILS

Websitehttp://www.apcure.com
Founded2012
Disease Focus
Development StageTechnology
STOCK CODENon Listed
Address
30, rue Pre-Gaudry 69007
Lyon
France
Email
Contact Number
+33 4 26 84 69 63

[atom_linkedin linkedin_option=”CompanyInsider” linkedin_id=”https://www.linkedin.com/company/apcure” connections=”true” suffix=””]

APCureÇs BacVac technology is based on a live, attenuated, bioengineered Pseudomonas aeruginosa strain. This bacterial vector has been made safe for use in patients and efficiently delivers tumor-cell specific marker, or Tumor Associated Antigen (TAA) to Antigen Presenting Cells, in vivo.